GWPH insider filings
GW PHARMACEUTICALS PLC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-05-07. Screen GWPH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for GWPH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — GW PHARMACEUTICALS PLC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-05-07 | 4 | Tovey Christopher J. — Chief Operating Officer | Disposition to issuer (D): 2,496 · Disposition to issuer (D): 52,560 (derivative) · Disposition to issuer (D): 6,468 (derivative) · Disposition to issuer (D): 58,884 (derivative) · Disposition to issuer (D): 119,340 (derivative) · Disposition to issuer (D): 17,904 (derivative) · +7 more | EDGAR |
| 2021-05-07 | 4 | Cline Darren S — U.S. Chief Commercial Officer | Disposition to issuer (D): 5,556 · Disposition to issuer (D): 54,192 (derivative) · Disposition to issuer (D): 22,068 (derivative) · Disposition to issuer (D): 98,040 (derivative) · Disposition to issuer (D): 106,320 (derivative) · Disposition to issuer (D): 177,180 (derivative) · +2 more | EDGAR |
| 2021-05-07 | 4 | Snyder Douglas B. — Chief Legal Officer | Disposition to issuer (D): 61,848 · Disposition to issuer (D): 82,956 (derivative) · Disposition to issuer (D): 63,252 (derivative) · Disposition to issuer (D): 46,644 (derivative) · Disposition to issuer (D): 9,180 (derivative) · Disposition to issuer (D): 9,612 (derivative) · +6 more | EDGAR |
| 2021-05-07 | 4 | Noble James — Director | Disposition to issuer (D): 27,492 · Disposition to issuer (D): 18,636 (derivative) · Disposition to issuer (D): 9,168 (derivative) · Disposition to issuer (D): 17,676 (derivative) · Disposition to issuer (D): 10,740 (derivative) · Disposition to issuer (D): 16,548 (derivative) · +3 more | EDGAR |
| 2021-05-07 | 4 | Secor Alicia — Director | Disposition to issuer (D): 10,584 · Disposition to issuer (D): 35,340 (derivative) · Disposition to issuer (D): 16,548 (derivative) · Disposition to issuer (D): 3,144 (derivative) · Disposition to issuer (D): 34,416 (derivative) · Disposition to issuer (D): 22,464 (derivative) | EDGAR |
| 2021-05-07 | 4 | Knappertz Volker — Chief Medical Officer | Disposition to issuer (D): 92,412 · Disposition to issuer (D): 150,444 (derivative) · Disposition to issuer (D): 55,536 (derivative) · Disposition to issuer (D): 48,252 (derivative) · Disposition to issuer (D): 12,156 (derivative) · Disposition to issuer (D): 8,436 (derivative) · +6 more | EDGAR |
| 2021-05-07 | 4 | MACKEY CATHERINE J — Director | Disposition to issuer (D): 10,536 · Disposition to issuer (D): 35,340 (derivative) · Disposition to issuer (D): 16,548 (derivative) · Disposition to issuer (D): 3,144 (derivative) · Disposition to issuer (D): 34,416 (derivative) · Disposition to issuer (D): 22,464 (derivative) | EDGAR |
| 2021-05-07 | 4 | Giacobello Scott M. — Chief Financial Officer | Disposition to issuer (D): 165,108 · Disposition to issuer (D): 67,164 (derivative) · Disposition to issuer (D): 68,460 (derivative) · Disposition to issuer (D): 44,184 (derivative) · Disposition to issuer (D): 8,136 (derivative) · Disposition to issuer (D): 10,404 (derivative) · +6 more | EDGAR |
| 2021-05-07 | 4 | GUY GEOFFREY W DR — Executive Chairman, Director | Disposition to issuer (D): 4,781,521 · Disposition to issuer (D): 25,000 · Disposition to issuer (D): 103,925 · Disposition to issuer (D): 138,672 (derivative) · Disposition to issuer (D): 15,336 (derivative) · Disposition to issuer (D): 107,352 (derivative) · +9 more | EDGAR |
| 2021-05-07 | 4 | Gover Justin D. — Chief Executive Officer, Director | Disposition to issuer (D): 222,773 · Disposition to issuer (D): 456,048 · Disposition to issuer (D): 1,867,308 · Disposition to issuer (D): 17,508 (derivative) · Disposition to issuer (D): 75,864 (derivative) · Disposition to issuer (D): 213,240 (derivative) · +13 more | EDGAR |
| 2021-05-07 | 4 | Brown Cabot — Director | Disposition to issuer (D): 7,200 · Disposition to issuer (D): 9,168 (derivative) · Disposition to issuer (D): 34,056 (derivative) · Disposition to issuer (D): 18,636 (derivative) · Disposition to issuer (D): 17,676 (derivative) · Disposition to issuer (D): 16,548 (derivative) · +3 more | EDGAR |
| 2021-05-07 | 4 | Waldegrave William A. — Director | Disposition to issuer (D): 35,340 (derivative) · Disposition to issuer (D): 7,164 (derivative) · Disposition to issuer (D): 16,548 (derivative) · Disposition to issuer (D): 9,432 (derivative) · Disposition to issuer (D): 34,416 (derivative) · Disposition to issuer (D): 22,464 (derivative) | EDGAR |
| 2021-05-07 | 4 | GRYSKA DAVID W — Director | Disposition to issuer (D): 35,208 (derivative) · Disposition to issuer (D): 22,464 (derivative) | EDGAR |
| 2021-04-08 | 4 | Snyder Douglas B. — Chief Legal Officer | Sale (S): 8,400 @ $18.12 | EDGAR |
| 2021-03-30 | 4 | Knappertz Volker — Director | Sale (S): 3,060 @ $18.10 | EDGAR |
| 2021-03-22 | 4 | Gover Justin D. — Chief Executive Officer, Director | Gift (G): 276,000 @ $0 | EDGAR |
| 2021-03-22 | 4 | Brown Cabot — Director | Sale (S): 4,020 @ $17.95 | EDGAR |
| 2021-03-04 | 4 | Giacobello Scott M. — Chief Financial Officer | Grant/award (A): 70,092 (derivative) @ $0 · Grant/award (A): 43,824 (derivative) @ $0 | EDGAR |
| 2021-03-04 | 4 | Cline Darren S — U.S. Chief Commercial Officer | Grant/award (A): 75,024 (derivative) @ $0 · Grant/award (A): 46,896 (derivative) @ $0 | EDGAR |
| 2021-03-04 | 4 | Gover Justin D. — Chief Executive Officer, Director | Grant/award (A): 263,184 (derivative) @ $0 · Grant/award (A): 164,496 (derivative) @ $0 | EDGAR |
| 2021-03-04 | 4 | Snyder Douglas B. — Chief Legal Officer | Grant/award (A): 72,258 (derivative) @ $0 · Grant/award (A): 45,360 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | MACKEY CATHERINE J — Director | Option exercise (M): 3,144 @ $0.00 · Tax withholding (F): 1,260 @ $17.85 · Option exercise (M): 3,144 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Secor Alicia — Director | Option exercise (M): 3,144 @ $0.00 · Tax withholding (F): 1,260 @ $17.85 · Option exercise (M): 3,144 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Brown Cabot — Director | Option exercise (M): 3,144 @ $0.00 · Tax withholding (F): 1,260 @ $17.85 · Option exercise (M): 3,144 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Snyder Douglas B. — Chief Legal Officer | Option exercise (M): 128,172 @ $0.00 · Tax withholding (F): 65,827 @ $17.90 · Option exercise (M): 9,612 @ $0.00 · Tax withholding (F): 4,937 @ $17.90 · Option exercise (M): 6,636 @ $0.00 · Tax withholding (F): 3,408 @ $17.85 · +3 more | EDGAR |
| 2021-03-02 | 4 | Knappertz Volker — Chief Medical Officer | Option exercise (M): 112,548 @ $0.00 · Tax withholding (F): 44,291 @ $17.90 · Option exercise (M): 8,448 @ $0.00 · Tax withholding (F): 3,325 @ $17.90 · Option exercise (M): 6,864 @ $0.00 · Tax withholding (F): 2,712 @ $17.85 · +3 more | EDGAR |
| 2021-03-02 | 4 | Gover Justin D. — Chief Executive Officer, Director | Option exercise (M): 22,440 @ $0.00 · Tax withholding (F): 11,086 @ $17.90 · Option exercise (M): 299,196 @ $0.00 · Tax withholding (F): 147,806 @ $17.90 · Option exercise (M): 24 @ $0.00 · Tax withholding (F): 12 @ $17.90 · +9 more | EDGAR |
| 2021-03-02 | 4 | Giacobello Scott M. — Chief Financial Officer | Option exercise (M): 138,756 @ $0.00 · Tax withholding (F): 72,649 @ $17.90 · Option exercise (M): 10,404 @ $0.00 · Tax withholding (F): 5,447 @ $17.90 · Option exercise (M): 6,288 @ $0.00 · Tax withholding (F): 3,300 @ $17.85 · +3 more | EDGAR |
| 2021-02-25 | 4 | Secor Alicia — Director | Grant/award (A): 22,464 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Knappertz Volker — Chief Medical Officer | Grant/award (A): 76,488 (derivative) @ $0 · Grant/award (A): 47,808 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | MACKEY CATHERINE J — Director | Grant/award (A): 22,464 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Cline Darren S — U.S. Chief Commercial Officer | Grant/award (A): 46,896 (derivative) @ $0 · Grant/award (A): 75,024 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Snyder Douglas B. — Chief Legal Officer | Grant/award (A): 45,324 (derivative) @ $0 · Grant/award (A): 72,528 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Gover Justin D. — Chief Executive Officer, Director | Grant/award (A): 164,496 (derivative) @ $0 · Grant/award (A): 263,184 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Brown Cabot — Director | Grant/award (A): 22,464 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Waldegrave William A. — Director | Grant/award (A): 22,464 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | GUY GEOFFREY W DR — Executive Chairman, Director | Grant/award (A): 131,712 (derivative) @ $0 · Grant/award (A): 82,320 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Giacobello Scott M. — Chief Financial Officer | Grant/award (A): 43,812 (derivative) @ $0 · Grant/award (A): 70,128 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Tovey Christopher J. — Chief Operating Officer | Grant/award (A): 67,440 (derivative) @ $0 · Grant/award (A): 42,192 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Noble James — Director | Grant/award (A): 22,464 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | GRYSKA DAVID W — Director | Grant/award (A): 22,464 (derivative) @ $0 | EDGAR |
| 2021-01-25 | 4 | George Adam D. — Secretary | Option exercise (M): 24,588 @ $9.61 · Sale (S): 23,388 @ $11.69 · Sale (S): 1,200 @ $11.76 · Option exercise (M): 14,700 @ $9.61 · Sale (S): 14,700 @ $11.69 · Option exercise (M): 24,588 (derivative) @ $0 · +1 more | EDGAR |
| 2021-01-20 | 4 | Knappertz Volker — Chief Medical Officer | Sale (S): 6,000 @ $11.67 | EDGAR |
| 2021-01-20 | 4 | George Adam D. — Secretary | Option exercise (M): 25,716 @ $10.61 · Option exercise (M): 52,560 @ $9.81 · Option exercise (M): 1,584 @ $9.61 · Sale (S): 53,376 @ $11.72 · Sale (S): 26,484 @ $11.75 · Option exercise (M): 9,600 @ $9.61 · +5 more | EDGAR |
| 2021-01-15 | 4 | George Adam D. — Secretary | Option exercise (M): 3,636 @ $0.00 · Option exercise (M): 97,008 @ $0.00 · Option exercise (M): 67,704 @ $3.72 · Option exercise (M): 99,180 @ $0.00 · Option exercise (M): 132,984 @ $0.00 · Option exercise (M): 78,336 @ $0.00 · +23 more | EDGAR |
| 2021-01-06 | 4 | Brown Cabot — Director | Option exercise (M): 3,576 @ $0.00 · Tax withholding (F): 1,440 @ $9.62 · Option exercise (M): 3,576 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | MACKEY CATHERINE J — Director | Option exercise (M): 3,576 @ $0.00 · Tax withholding (F): 1,440 @ $9.62 · Option exercise (M): 3,576 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Secor Alicia — Director | Option exercise (M): 3,576 @ $0.00 · Tax withholding (F): 1,440 @ $9.62 · Option exercise (M): 3,576 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Gover Justin D. — Chief Executive Officer, Director | Gift (G): 456,048 @ $0 · Gift (G): 456,048 @ $0 | EDGAR |
| 2020-12-14 | 4 | GUY GEOFFREY W DR — Executive Chairman, Director | Sale (S): 79,596 @ $10.80 · Sale (S): 55,332 @ $10.87 · Sale (S): 136,656 @ $10.97 · Sale (S): 85,980 @ $11.04 · Sale (S): 69,156 @ $11.13 · Sale (S): 14,340 @ $11.19 · +5 more | EDGAR |
Recent 8-K events — GW PHARMACEUTICALS PLC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-05-05 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-04-26 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-04-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-04-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-03-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-02-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-11-03 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GWPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs